Approval · Notice of Compliance 9430 · 2008
ALTARGO: Notice of Compliance 9430
Issued March 19, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9430
- Date
- March 19, 2008
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALTARGO | 02307502 | Cancelled Pre Market |
Medicinal ingredients
- RETAPAMULIN 1 PER